Latest Regulatory News

BWP Group has announced its actual interim distribution of AUD 0.0958 per stapled security for the half-year ending December 2025, alongside details of its Dividend Reinvestment Plan.

Cochlear Limited reported a modest 1% rise in sales but a 9% fall in underlying net profit for the half year ended December 2025, as the rollout of its innovative Nucleus Nexa System faced longer-than-expected regulatory and contract hurdles. The company anticipates a robust second half driven by broader product availability and service growth.

Cochlear Limited posted a modest 1% increase in sales revenue for the half year ending December 2025, while underlying net profit fell 9%, impacted by cloud computing costs and a slower-than-expected Nexa System rollout. The company maintains its dividend and outlines cautious FY26 guidance.

Westpac Banking Corporation reported a steady net profit of AUD 1.9 billion for the first quarter of 2026, underpinned by stable margins and robust capital ratios. The bank’s credit quality and funding position remain resilient amid a cautious economic outlook.

Westpac Banking Corporation reported a 6% rise in net profit for the first quarter of 2026, underpinned by strong capital ratios and ongoing transformation initiatives. The bank’s strategic focus on customer service and operational efficiency signals a confident outlook amid evolving market conditions.

Verity Resources Limited has announced a pro-rata entitlement issue to raise up to $2.05 million, partially underwritten by entities linked to its directors. The capital raise aims to fund exploration and technical studies across its key projects, including the Monument Gold Project.

Bannerman Energy has secured a landmark $321.5 million strategic investment from CNNC Overseas Limited to jointly develop the Etango Uranium Project in Namibia, enabling debt-free construction and a market-priced offtake agreement with a Tier-1 nuclear utility.

Northern Star Resources has reported a robust half-year result with a 41% jump in net profit, driven by soaring gold prices despite operational setbacks. The company also announced a fully franked interim dividend of 25 cents per share.

Assetora Limited is set to be delisted from the ASX after a two-year suspension, with the company exploring a fresh listing on the National Stock Exchange of Australia to better suit its evolving business model.

BPH Global has clarified the timing and rationale behind its disclosure of a binding Memorandum of Understanding with Indonesia’s National Research and Innovation Agency, confirming compliance with ASX rules.

Podium Minerals has disclosed the initial securities interests of its newly appointed directors, highlighting a significant allocation of performance rights to Gary Humphries while Neal Froneman holds none.

Invex Therapeutics reports a net loss of $715,582 for H1 2026 while advancing its Exenatide program targeting neurological diseases, alongside notable board reshuffles.